A Study of AG-636 in the Treatment of Subjects With Advanced Lymphoma
Clinical trial NCT03834584 · TERMINATED
Trial details
- NCT number
- NCT03834584
- Sponsor
- Agios Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-24
- Primary completion
- 2020-06-17
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.